Bilateral Intracranial Beta Activity During Forced and Spontaneous Movements in a 6-OHDA Hemi-PD Rat Model
نویسندگان
چکیده
Cortico-basal ganglia beta oscillations (13–30 Hz) are assumed to be involved in motor impairments Parkinson’s Disease (PD), especially bradykinesia and rigidity. Various studies have utilized the unilateral 6-hydroxydopamine (6-OHDA) rat PD model further investigate test novel treatments. However, a detailed behavioral electrophysiological characterization of model, including analyses popular treatments such as DBS, has not been documented literature. We hence challenged 6-OHDA hemi-PD with series experiments (i.e., cylinder test, open field rotarod test) aimed at assessing impairments, analyzing effects Deep Brain Stimulation (DBS), identifying under which conditions excessive occur. found that rats presented an impaired performance all compared sham group, DBS could improve their overall performance. Across behaviors, power high band was observed important biomarker for it showed differences between healthy lesioned hemispheres 6-OHDA-lesioned rats. This shows accurately represents many symptoms makes useful tool pre-clinical testing new when low β (13–21 (21–30 frequency bands considered separately.
منابع مشابه
Identification of Bilateral Changes in TID1 Expression in the 6-OHDA Rat Model of Parkinson's Disease
Parkinson's disease (PD) is a common neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra and the aggregation of α-synuclein into Lewy bodies. Existing therapies address motor dysfunction but do not halt progression of the disease. A still unresolved question is the biochemical pathway that modulates the outcome of protein misfolding and aggregatio...
متن کاملThe Flavonoid Hesperetin Alleviates Behavioral Abnormality in 6-Hydroxydopamine Rat Model of Hemi-Parkinsonism
ABSTRACTParkinson’s disease (PD) is a neuropathological and debilitating disorder involving the degeneration of mesencephalic dopaminergic neurons. Neuroprotective effect of hesperetin has already been reported, therefore, this study examined whether the administration of this flavonoid would attenuate behavioral abnormalities in an experimental model of PD in rat. For this purpose, unilateral ...
متن کاملProtective Effect of Carvacrol in 6-hydroxydopamine Hemi-parkinsonian Rat Model
Background and Objective: A huge amount of investigational evidence support a role for oxidative stress as an intermediary of nerve cell dysfunction in Parkinson’s disease (PD). Polyphenols such as carvacrol have been indicated to prevent neuronal deterioration caused by increased oxidative load, thus, this study evaluated whether carvacrol administration would attenuate behavioral abnormalitie...
متن کاملSpontaneous locomotor activity and L-DOPA-induced dyskinesia are not linked in 6-OHDA parkinsonian rats
Bradykinesia (slowness of movement) and other characteristic motor manifestations of Parkinson's disease (PD) are alleviated by treatment with L-dihydroxyphenylalanine (L-DOPA). Long-term L-DOPA treatment, however, is associated with complications such as motor fluctuations and dyskinesia that severely impair the quality of life. It is unclear whether the effect of L-DOPA on spontaneous motor a...
متن کاملProtective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease.
Stem cell-based therapy is a promising treatment for neurodegenerative diseases. In our laboratory, a novel protocol has been developed to induce bone marrow-derived mesenchymal stem cells (MSC) into neurotrophic factors- secreting cells (NTF-SC), thus combining stem cell-based therapy with the NTF-based neuroprotection. These cells produce and secrete factors such as brain-derived neurotrophic...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in Neuroscience
سال: 2021
ISSN: ['1662-453X', '1662-4548']
DOI: https://doi.org/10.3389/fnins.2021.700672